Sagimet Biosciences (SGMT) EBITDA Margin (2023)
Sagimet Biosciences (SGMT) has 1 years of EBITDA Margin data on record, last reported at 317.65% in Q3 2023.
- For Q3 2023, EBITDA Margin changed N/A year-over-year to 317.65%; the TTM value through Jun 2024 reached 1463.7%, changed N/A, while the annual FY2023 figure was 1388.1%, N/A changed from the prior year.
- EBITDA Margin reached 317.65% in Q3 2023 per SGMT's latest filing.
- Across five years, EBITDA Margin topped out at 317.65% in Q3 2023 and bottomed at 317.65% in Q3 2023.